探索过氧体增殖器激活受体和内皮功能障碍在代谢功能障碍相关的稳态性肝病中的作用
相关实验视频
Updated: Jun 3, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Ana Paula Madariaga Traconis1,2, Misael Uribe-Esquivel3, Varenka Julieta Barbero Becerra1
1Translational Research Unit, Medica Sur Clinic & Foundation, Mexico City 14050, Mexico.
过氧体增殖器激活受体 (PPAR) 在治疗内皮功能障碍和与代谢功能障碍相关的脂肪性肝病 (MASLD) 中表现有前途. 在MASLD患者中,PPAR激动剂可能会改善代谢,肝脏和心血管健康.
科学领域:
- 血管生物学 血管生物学
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 与心血管疾病相关的内皮功能障碍,经常与代谢功能障碍相关的脂肪性肝病 (MASLD) 共存.
- MASLD的特点是氧化的可用性降低,导致肝细胞激活和炎症.
- 核激素受体,特别是氧酶增殖器激活受体 (PPAR),是肠-肝-脂肪轴,新陈代谢和炎症的关键调节者.
研究的目的:
- 审查PPARs在内皮功能障碍和MASLD中的作用.
- 探索PPARs影响疾病进展的机制.
- 讨论PPARs作为MASLD和相关内皮功能障碍的药理学标的潜力.
主要方法:
- 关于PPARs,内皮功能障碍和MASLD的研究的文献综述.
- 分析涉及PPARs在代谢和炎症途径中的机制.
- 对MASLD中PPAR激动剂的临床和实验数据的检查.
主要成果:
- PPARs显著影响肠-肝-脂肪轴,新陈代谢和炎症.
- 拉尼菲布拉诺和埃拉菲布拉诺等PPAR激动剂显示出潜在的治疗益处.
- 针对PPAR可能为管理MASLD和内皮功能障碍提供一种新的策略.
结论:
- PPARs对于调节血管平衡和代谢健康至关重要.
- PPAR激动剂代表了对MASLD及其心血管相关疾病的有前途的治疗途径.
- 对PPAR机制的进一步研究可以优化药理向,以改善患者的治疗结果.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
相关概念视频
Peroxisomes
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Cell Specific Gene Expression